NEXGEL (NASDAQ: NXGL) reported Q2 EPS of ($0.19), $0.05 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $561 thousand versus the consensus estimate of $546 thousand.

For earnings history and earnings-related data on NEXGEL (NXGL) click here.